Rulemaking History for OTC Allergy Drug Products

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research

Rulemaking History for OTC Allergy Drug Products
View by Date

Final Monograph (21 CFR part 341):
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use

OTC Allergy Drug Products found on this page:

Note: This page links to PDF files which require the free Adobe Acrobat Reader.

**Allergy Drug Products: Antihistamines for Cold Symptoms**
Advance Notice Of Proposed Rulemaking	Date	FR Citation
Advance Notice of Proposed Rulemaking	9/9/1976	41FR38312
Reopening of Administrative Record	3/21/1980	45FR18400
Notice: Advisory Committee meeting	4/29/1983	48FR19470
Notice: Republication of 4/29/1983 notice	5/6/1983	48FR20502
Proposed Rule	Date	FR Citation
Proposed Rule	1/15/1985	50FR2200
Correction	2/14/1985	50FR6199
Correction	3/6/1985	50FR9040
Final Rule	Date	FR Citation
Final Rule	12/9/1992	57FR58356

**Allergy Drug Products: Chlorocyclizine HCl and Doxylamine Succinate**
Proposed Rule	Date	FR Citation
Proposed Rule: Chlorocyclizine HCl and doxylamine succinate	8/24/1987	52FR31892
Correction	9/22/1987	52FR35610
Final Rule	Date	FR Citation
Final Rule: doxylamine succinate	1/28/1994	59FR4216

**Allergy Drug Products: Bronchodilators for Asthma Symptoms**
Proposed Rule	Date	FR Citation
Tentative Final Monograph	10/26/1982	47FR47520
Notice: Advisory Committee meeting on metaproterenol	4/29/1983	48FR19470
Notice: Advisory Committee meeting on metaproterenol	5/6/1983	48FR20502

Date created: December 28, 2006; Last updated: May 4, 2007